Stock Quote

 
$0.40
23 Oct 2009
+0.00%
$0.40
--
18,040
$0.40
$0.40
$2.69
$0.15
0.56
0

Research Another Stock: Symbol Look-up
No news stories for this company within the last 30 days.
XTENT Extends a Lesson in Shorting Biotechs
Sunday, 7 Jun 2009 09:28am EDT(Seeking Alpha) 
The Ten Most Promising Net Cash Stocks
Thursday, 19 Mar 2009 03:13am EDT(SeekingAlpha) 
 
Name Current Position Compensation
Plain, Henry Chairman of the Board --
Casciaro, Gregory President, Chief Executive Officer, Director 1,132,810
Kahlenberg, Timothy Chief Financial Officer 812,074

Profile

XTENT, Inc. is a development-stage medical device company focused on developing and commercializing drug eluting stent (DES), systems for the treatment of coronary artery disease (CAD). The DES systems are designed to enable physicians to customize both length and diameter of the stent at the site... Full Description

Company Address

Xtent, Inc.
125 Constitution Drive
Menlo Park   CA   94025
P: +1650.4759400
F: +1650.4759401

Analyst Research

Performance of Key Competitors

Company Price Change
Abbott Laboratories $54.08 -0.33
Boston Scientific Corporation $8.50 -0.14
Johnson & Johnson $62.89 -0.41
  XTNT.OQ Industry
P/E(TTM) -- 8.26
P/S(TTM) -- 0.54
ROI(TTM) -120.42 1.17
ROE(TTM) -120.42 1.71
Consensus Recommendation
EPS Est. (Current Period) --
EPS Est. (Current Year) --
Total Revenue $0.00M
Net Income $-2.12M
EPS $-0.09